MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesVascular Remodelling and Mesenchymal Transition in Systemic SclerosisMicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic SclerosisRole of the microRNA-29 family in fibrotic skin diseases.MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosisA comprehensive expression profile of micrornas in rat's pituitaryGlycoprofiling as a novel tool in serological assays of systemic sclerosis: a comparative study with three bioanalytical methods.Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts.Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patientsResults of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.The role of microRNAs in autoimmune diseases with skin involvement.Identification of cytokine-induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay.Suppressive effects of human fetal keratinocytes on the proliferation, differentiation and extracellular matrix synthesis of human hypertrophic scar fibroblasts in vitro.The Role of MicroRNAs in Arterial Stiffness and Arterial Calcification. An Update and Review of the Literature.Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.Human Fibrotic Diseases: Current Challenges in Fibrosis Research.MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
P2860
Q26748338-9C557FF3-12AA-4607-9D95-B868860A64F8Q26749091-8F76FCE2-36BF-42CC-8115-20E43DA43B20Q26781257-4E3F7F5A-6720-4DB1-B25D-D1BE5634F170Q33742115-E0B2495B-AEA2-4003-88E4-2CE8D0F873EBQ34790405-A63733E0-8AAC-4AE7-B6E9-0E7E9137C877Q36183015-34583831-6D9C-4A69-BC13-664DFE91AE5BQ36943783-90E13D63-8718-4DC3-841F-97AF43E1C5CFQ36965488-AE20DA19-0759-4AF6-A9C5-28087BD5EF2EQ37648637-1EF71004-6D9F-4B33-8551-3636BA93D794Q38204104-ACCA512F-5638-4DAC-94E0-DEC1AEAF4D93Q38222306-DC549D3B-4CA8-48DD-B1EF-BA5F9406796FQ38272151-D220C9B1-7658-4B46-985E-7ECE912AF035Q41141524-6F5CEFA0-EE8E-44F5-9594-FB2DE3A48123Q42679016-6E8F9F2D-08D0-464A-8303-00C845A254AEQ49180731-EE63A55A-B413-467C-888F-51F2536E700DQ52348476-EE5BD9D4-1E2D-4C97-822F-5FF0EF564587Q52536468-5F10782D-01A1-40C6-999C-24CD21E3CF47Q53651758-3C2EE64A-9293-4FC1-BEBD-EE17AA621FF8
P2860
MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
MicroRNAs: their involvement i ...... tic biomarkers in scleroderma.
@en
type
label
MicroRNAs: their involvement i ...... tic biomarkers in scleroderma.
@en
prefLabel
MicroRNAs: their involvement i ...... tic biomarkers in scleroderma.
@en
P2093
P2860
P921
P356
P1476
MicroRNAs: their involvement i ...... tic biomarkers in scleroderma.
@en
P2093
P2860
P2888
P356
10.1038/EMM.2013.71
P5008
P577
2013-09-20T00:00:00Z
P5875
P6179
1019716310